Navigation Links
Researcher awarded $1.8 million grant to study gender differences in antidepressant effects
Date:8/15/2013

TALLAHASSEE, Fla. In low doses, the general anesthetic drug ketamine works as an antidepressant, and for females the boost in mood is easier to achieve.

A Florida State University College of Medicine researcher is learning more about why this drug, used as an antidepressant for the last decade, requires a higher dosage to improve depression in males.

Mohamed Kabbaj, a professor in the Department of Biomedical Sciences at the College of Medicine, received a $1.8 million grant from the National Institute of Mental Health to support his research.

"The first purpose is to show the molecular mechanism behind the hormones estrogen and progesterone that are enhancing the effect of ketamine in females," Kabbaj said. "The other purpose of the grant is to determine whether males will respond to estrogen and progesterone in addition to ketamine administered at a low dose."

Researchers are interested in looking for ways around giving higher doses of ketamine to males because of the drug's side effects.

"At medium and high doses, ketamine can create dissociation from one's surroundings," Kabbaj said. "It's also an addictive drug, and you cannot give it chronically."

Administering ketamine with a combination of estrogen and progesterone, which are more abundant in females, may diminish some of these side effects. Kabbaj and his team continue investigating ketamine despite its side effects because of its quick antidepressant response time.

"Ketamine is used as an antidepressant in clinics now because it takes effect acutely," Kabbaj said. "Two hours after one low dose, patients feel better. The classic antidepressants take two to three weeks to work."

This quick, low-dose effect can be a lifesaver for suicidal patients whose repeated thoughts of harming themselves make time a precious commodity. It is also used as an alternative to electroconvulsive shock therapy, which depressive patients sometimes refuse.

But Kabbaj's research has shown that gender differences must be considered.

"Even with classic antidepressants there are studies showing that men and women respond differently to different classes of antidepressant drugs," Kabbaj said. "Their brains are different, so we need to find out if there are treatments that work better in women and treatments that work better in men."

Kabbaj wants to know whether striking the right balance between ketamine, progesterone and estrogen in both genders will allow for safer use of ketamine as an ongoing treatment for depression, so that it can treat those in need of immediate relief from depression without the secondary effects.


'/>"/>

Contact: Julie Jordan
julie.jordan@med.fsu.edu
850-645-9699
Florida State University
Source:Eurekalert

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
4. Researchers Find Gene Mutations That May Be a Key to Autism
5. Researchers find evidence of banned antibiotics in poultry products
6. NJ stroke researchers report advances in spatial neglect research at AAN Conference
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. Stress contributes to cognitive declines in women with breast cancer, researcher says
9. Researchers Map Brain Regions Linked to Intelligence
10. Researchers ID Genes That May Determine Mental Illness
11. Researchers Develop Blood Test for Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... 2017 , ... Young Asset Protection, an insurance provider and ... greater Pittsburgh metropolitan region, is joining forces with the local chapter of the ... , Variety the Children’s Charity is a national organization dedicated to empowering, enabling, ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Hong Kong Polytechnic University (PolyU) ... facility among higher education institutions in Hong Kong to support teaching, learning and research. ... range and quantity of facilities in Hong Kong. , With an area of ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... ... Joseph Health held the much anticipated Regional Primary Care Spring Symposium on April ... in the local medical community, offering physicians and healthcare providers an opportunity to ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... ... to experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become ... privilege to help my numerous clients over the years with all their dental needs,” ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... Detroit reveals good news for older shoulder replacement patients; post-operative recovery just might ... from two groups of patients presenting with osteoarthritis following surgery: 262 patients under ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Research and Markets has announced the ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ... ... will rise from USD 20 Billion in 2015 to around USD ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
Breaking Medicine Technology: